The facts are hard to ignore: rising rates of chronic disease, epidemic obesity and diabetes, a widening longevity gap between rich and poor, health care “reforms” at odds with patient interests. In response, Policy Innovations for Health argues that a nation’s well-being mirrors the health of its citizens—and calls not only for improvement in our health care systems but for a complete reconceptualization of health and social policy, starting with expanded, interrelated roles for health care providers, consumers, and policymakers. The long-term strategies outlined in this book emphasize a stronger balance between public and individual health goals, and collaborations between cost-efficient, streamlined medical care and innovative therapeutic research and technology—values that have been traditionally been considered in conflict. Examples are included of new care models and groundbreaking programs from Canada, the EU, and Australia that bring together the community, consumer, governmental, and corporate sectors; bridge the gaps between prevention, health promotion, and practice; and improve core health determinants such as living conditions, education, and social supports. These social, political, medical, and technological advances, assert the authors, are crucial to meeting the challenges of the decades ahead. Among the topics covered: Health as a central economic and societal force. New directions in the monitoring of health and well-being. “Integrating Health in all Policies” programs and how they can be implemented. The democratization of health knowledge and the expanding role of patient participation. Closing the financial divide in public health priority-setting. Policy Innovations for Health adds important new voices to the health care debate, and its vision will inspire professionals in health policy, health administration, health economics, and global health, as well as graduate students planning to enter these rapidly changing fields.

A calculation of the social returns to innovation /Benjamin F. Jones and Lawrence H. Summers --Innovation and human capital policy /John Van Reenen --Immigration policy levers for US innovation and start-ups /Sari Pekkala Kerr and William R. Kerr --Scientific grant funding /Pierre Azoulay and Danielle Li --Tax policy for innovation /Bronwyn H. Hall --Taxation and innovation: what do we know? /Ufuk Akcigit and Stefanie Stantcheva --Government incentives for entrepreneurship /Josh Lerner.

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.

'The book would be a great text for advanced healthcare students, as it is chock-full of fair-minded and complete discussions of different scholarly views. The book contains the musts of excellent text books too: ample caselets, boxes and figures that illustrate key concepts; chapter summaries; and a distillation of key concepts and further reading suggestions stud every chapter. It is useful for practitioners too, with excellent text and case examples of how different nations approach innovation and quality measurement — e.g. pay for performance models — and full discussions of regulations of drugs and devices. All in all, a terrific book for those of us frustrated by the plethora of ‘shoulds’ and the shortages of ‘how tos’ in healthcare innovations.'Regina HerzlingerHarvard Business SchoolAcross the world, the demands placed on health systems are growing rapidly. Developed countries face the challenge of providing services to an ageing population with changing health needs, while countries with developing health systems must find ways of ensuring their populations are provided with access to healthcare. Innovative thinking is essential to meet these twin challenges, but innovation is both a cause and cure of many struggles in healthcare — we need it, but it is hard to manage and the introduction of new technology can lead to higher costs.Using real-life examples and case studies from around the world, this book introduces the latest thinking on understanding and managing healthcare innovation more effectively. It does this from the perspective of governments responsible for shaping health policy, healthcare organisations providing services and juggling competing demands, and from the perspective of the industries that supply the new drugs, devices and other technologies.Managing Innovation in Healthcare is the perfect accompaniment for MSc, PhD and MBA students on health policy, management and public health courses, as well as managers, consultants and policy makers involved in healthcare services in both the public and private sector.

This book provides an extensive review of what innovation means in healthcare, with real-life examples and guidance on how to successfully innovate with IT in healthcare.

The Business of Healthcare Innovation is the first wide-ranging analysis of business trends in the manufacturing segment of the health care industry. In this leading edge volume, Professor Burns focuses on the key role of the 'producers' as the main source of innovation in health systems. Written by professors of the Wharton School and industry executives, this book provides a detailed overview of the pharmaceutical, biotechnology, genomics/proteomics, medical device and information technology sectors. It analyses the market structures of these sectors as well as the business models and corporate strategies of firms operating within them. Most importantly, the book describes the growing convergence between these sectors and the need for executives in one sector to increasingly draw upon trends in the others. It will be essential reading for students and researchers in the field of health management, and of great interest to strategy scholars, industry practitioners and management consultants.

Innovation in Health Informatics: A Smart Healthcare Primer explains how the most recent advances in information and communication technologies have paved the way for new breakthroughs in healthcare. The book showcases current and prospective applications in a context defined by an imperative to deliver efficient, patient-centered and sustainable healthcare systems. Topics discussed include big data, medical data analytics, artificial intelligence, machine learning, virtual and augmented reality, 5g and sensors, Internet of Things, nanotechnologies and biotechnologies. Additionally, there is a discussion on social issues and policy- making for the implementation of smart healthcare. This book is a valuable resource for undergraduate and graduate students, practitioners, researchers, clinicians and data scientists who are interested in how to explore the intersections between bioinformatics and health informatics. - Provides a holistic discussion on the new landscape of medical technologies, including big data, analytics, artificial intelligence, machine learning, virtual and augmented reality, 5g and sensors, Internet of Things, nanotechnologies and biotechnologies - Presents a case study driven approach, with references to real-world applications and systems - Discusses topics with a research-oriented approach that aims to promote research skills and competencies of readers

A wave of new health care innovation and growing demand for health care, coupled with uncertain productivity improvements, could severely challenge efforts to control future health care costs. A committee of the National Research Council and the Institute of Medicine organized a conference to examine key health care trends and their impact on medical innovation. The conference addressed the following question: In an environment of renewed concern about rising health care costs, where can public policy stimulate or remove disincentives to the development, adoption and diffusion of high-value innovation in diagnostics, therapeutics, and devices?

This thought-provoking study examines the ethical, legal, and social problems that arise with cutting-edge medical technology. Using as examples four powerful and largely unregulated technologies—off-label use of drugs, innovative surgery, assisted reproduction, and neuroimaging—Margaret L. Eaton and Donald Kennedy illustrate the difficult challenges faced by clinicians, researchers, and policy makers who seek to advance the frontiers of medicine safely and responsibly. Supported by medical history and case studies and drawing on reports from dozens of experts, the authors address important practical, ethical, and policy issues. They consider topics such as the responsible introduction of new medical products and services, the importance of patient consent, the extent of the duty to mitigate harm, and the responsibility to facilitate access to new medical therapies. This work's insights into the nature and consequences of medical innovation contribute to the national debate on how best to protect patients while fostering innovation and securing benefits.

Health-Care Solutions from a Distant Shore Health care in the United States and other nations is on a collision course with patient needs and economic reality. For more than a decade, leading thinkers, including Michael Porter and Clayton Christensen, have argued passionately for value-based health-care reform: replacing delivery based on volume and fee-for-service with competition based on value, as measured by patient outcomes per dollar spent. Though still a pipe dream here in the United States, this kind of value-based competition is already a reality--in India. Facing a giant population of poor, underserved people and a severe shortage of skills and capacity, some resourceful private enterprises have found a way to deliver high-quality health care, at ultra-low prices, to all patients who need it. This book shows how the innovations developed by these Indian exemplars are already being practiced by some far-sighted US providers--reversing the typical flow of innovation in the world. Govindarajan and Ramamurti, experts in the phenomenon of reverse innovation, reveal four pathways being used by health-care organizations in the United States to apply Indian-style principles to attack the exorbitant costs, uneven quality, and incomplete access to health care. With rich stories and detailed accounts of medical professionals who are putting these ideas into practice, this book shows how value-based delivery can be made to work in the United States. This "bottom-up" change doesn't require a grand plan out of Washington, DC, agreement between entrenched political parties, or coordination among all players in the health-care system. It needs entrepreneurs with innovative ideas about delivering value to patients. Reverse innovation has worked in other industries. We need it now in health care.